Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Payables (2020 - 2025)

Cellebrite DI (CLBT) has 6 years of Payables data on record, last reported at $16.8 million in Q4 2025.

  • For Q4 2025, Payables fell 73.42% year-over-year to $16.8 million; the TTM value through Dec 2025 reached $16.8 million, down 73.42%, while the annual FY2025 figure was $16.8 million, 73.42% down from the prior year.
  • Payables reached $16.8 million in Q4 2025 per CLBT's latest filing, down from $63.3 million in the prior quarter.
  • Across five years, Payables topped out at $63.3 million in Q4 2024 and bottomed at $4.6 million in Q4 2022.
  • Average Payables over 5 years is $29.4 million, with a median of $16.8 million recorded in 2025.
  • Peak YoY movement for Payables: skyrocketed 1043.3% in 2021, then plummeted 91.47% in 2022.
  • A 5-year view of Payables shows it stood at $54.0 million in 2021, then tumbled by 91.47% to $4.6 million in 2022, then surged by 79.58% to $8.3 million in 2023, then skyrocketed by 664.67% to $63.3 million in 2024, then tumbled by 73.42% to $16.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $16.8 million in Q4 2025, $63.3 million in Q4 2024, and $8.3 million in Q4 2023.